These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 25721957)

  • 1. Motor neurone disease: bringing New Zealand patients onto the world stage.
    Scotter EL
    N Z Med J; 2015 Feb; 128(1409):12-4. PubMed ID: 25721957
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence of motor neurone disease in Hawke's Bay and Gisborne/East Coast.
    Baker PC
    N Z Med J; 2015 May; 128(1413):79-80. PubMed ID: 26101125
    [No Abstract]   [Full Text] [Related]  

  • 3. Environmental health and social factors associated with motor neurone disease.
    Cherry N
    Aust N Z J Public Health; 2002 Dec; 26(6):574. PubMed ID: 12530805
    [No Abstract]   [Full Text] [Related]  

  • 4. Respiratory management of motor neurone disease: a review of current practice and new developments.
    Rafiq MK; Proctor AR; McDermott CJ; Shaw PJ
    Pract Neurol; 2012 Jun; 12(3):166-76. PubMed ID: 22661348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motor neurone disease in the greater Wellington region: an observational study.
    Dayal V; Rosemergy I; Turnbull J
    N Z Med J; 2015 Feb; 128(1409):29-34. PubMed ID: 25721959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motor neurone disease--a study of prevalence and disability.
    James CM; Harper PS; Wiles CM
    QJM; 1994 Nov; 87(11):693-9. PubMed ID: 7820544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of an Australian motor neurone disease registry.
    Kiernan MC; Talman P; Henderson RD; Harris R;
    Med J Aust; 2006 Apr; 184(7):367-8. PubMed ID: 16584377
    [No Abstract]   [Full Text] [Related]  

  • 8. Motor neuron disease mortality rates in New Zealand 1992-2013.
    Cao MC; Chancellor A; Charleston A; Dragunow M; Scotter EL
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 May; 19(3-4):285-293. PubMed ID: 29382218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk estimates for developing motor neurone disease in first-degree relatives.
    James CM; Newcombe RG; Harper PS; Wiles CM
    Clin Genet; 1995 Jan; 47(1):13-6. PubMed ID: 7774037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motor neurone disease and military service: evidence from the Scottish Veterans Health Study.
    Bergman BP; Mackay DF; Pell JP
    Occup Environ Med; 2015 Dec; 72(12):877-9. PubMed ID: 26468494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caring for patients with motor neurone disease.
    Skelton J
    Nurs Stand; 1996 May; 10(32):33-6. PubMed ID: 8716359
    [No Abstract]   [Full Text] [Related]  

  • 12. Motor neurone disease.
    Nurs Stand; 2016 Mar; 30(30):17; discussion 17. PubMed ID: 27008127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motor neurone disease: clinical features, diagnosis, diagnostic pitfalls and prognostic markers.
    Sathasivam S
    Singapore Med J; 2010 May; 51(5):367-72; quiz 373. PubMed ID: 20593140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motor neurone disease: a progressive disease requiring a coordinated approach.
    Thomas S
    Prof Nurse; 1993 Jun; 8(9):583-5. PubMed ID: 8511157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of radiogenic lower motor neurone disease, a possible link with a preceding viral infection.
    Esik O; Vönöczky K; Lengyel Z; Sáfrány G; Trón L
    Spinal Cord; 2004 Feb; 42(2):99-105. PubMed ID: 14765142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The development of the UK National Institute of Health and Care Excellence evidence-based clinical guidelines on motor neurone disease.
    Oliver D; Radunovic A; Allen A; McDermott C
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Aug; 18(5-6):313-323. PubMed ID: 28513234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of motor neurone disease in the Province of Alberta.
    Svenson LW; Cwik VA; Martin WR
    Can J Neurol Sci; 1999 May; 26(2):119-22. PubMed ID: 10352871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regarding 'access to palliative care for people with motor neurone disease in New Zealand'.
    MacLennan A
    N Z Med J; 2005 Oct; 118(1224):U1710. PubMed ID: 16258582
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular and cellular pathways of neurodegeneration in motor neurone disease.
    Shaw PJ
    J Neurol Neurosurg Psychiatry; 2005 Aug; 76(8):1046-57. PubMed ID: 16024877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Access to palliative care for people with motor neurone disease in New Zealand: a patient's perspective.
    Williams B
    N Z Med J; 2005 Oct; 118(1224):U1711. PubMed ID: 16258583
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.